Quantcast
Last updated on April 17, 2014 at 15:43 EDT

Latest Peripheral membrane proteins Stories

2012-01-12 08:15:00

VIENNA, Jan. 12, 2012 /PRNewswire/ -- CSL Behring has announced that the first site has been initiated in its global phase II/III, multi-center study to evaluate the safety, efficacy and pharmacokinetics of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP). The site is located in Vienna, Austria. The prospective, open-label study will enroll adolescents and adults (12 - 65 years) who have hemophilia B. CSL Behring, in collaboration with...

2011-12-22 06:30:00

CAMBRIDGE, Mass., Dec. 22, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration), the only biopharmaceutical company focused exclusively on the development and commercialization of new treatment options for people with hemophilia, announced today the Company will relocate its corporate headquarters to Cambridge, MA from Laguna Niguel, CA. The move is integral to Inspiration's plan to accommodate its anticipated future staffing and facility needs as the...

2011-12-16 13:59:19

Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease. Now, researchers have found that different variants of NACP-Rep1 and its interaction with the microtubule-associated protein tau (MAPT) H1 haplotype can influence the speed of clinical...

2011-12-12 13:28:32

Discovery of subcellular processing location and target signal of cyclotide kalata B1 Many plants produce compounds that serve as a defense against predators or pathogens. Some are also used by humans for a variety of beneficial purposes, such as in medicines. As recently as the early 1990s, a unique class of proteins previously unknown to science, the cyclotides, was discovered. First noted through African tribal use as a tea given to speed up delivery during childbirth, cyclotides have...

2011-12-12 06:30:00

LAGUNA NIGUEL, Calif., Dec. 12, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) has presented key scientific data from the Company's two lead hemophilia development programs - IB1001, a recombinant factor IX (FIX) product, which is in clinical trials for the treatment and prevention of bleeding in individuals with hemophilia B; and OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, which is being evaluated for the treatment of...

2011-12-01 01:47:31

New research in the FASEB Journal suggests that phosphorylated alpha-synuclein, a substance found in the blood of Parkinson's patients, could lead to definitive diagnostic tool A new research report appearing in the December issue of the FASEB Journal (http://www.fasebj.org) shows how scientists from the United Kingdom have developed a simple blood test to detect Parkinson's disease even at the earliest stages. The test is possible because scientists found a substance in the blood, called...

2011-11-28 00:30:00

LAGUNA NIGUEL, Calif., Nov. 28, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program. In the newly initiated clinical study, OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, will be evaluated for the treatment of individuals with congenital hemophilia A who have developed inhibitory antibodies...

2011-11-11 08:44:00

CHICAGO, Nov. 11, 2011 /PRNewswire/ -- At a special ceremony at the National Hemophilia Foundation (NHF) Annual Meeting in Chicago, Bayer HealthCare and members of the hemophilia community commemorated the successful conclusion of Bayer's first Virtual Walk for Hemophilia (www.walkforhemophilia.com), an innovative interactive contest that raises awareness and funds for those living with a bleeding disorder. Bayer also kicked off year two of the Virtual Walk as a means of continued support...

2011-10-12 02:00:00

NEW YORK and VIENNA, Austria, Oct. 12, 2011 /PRNewswire-USNewswire/ --The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE® PD01, a first-of-its-kind Parkinson's disease (PD) vaccine. AFFITOPE® PD01 targets and helps remove the alpha-synuclein protein, whose clumping is the pathological hallmark of PD. Principal investigator Achim...

2011-10-07 13:50:00

Ascent Scientific, together with Freie Universität Berlin, The University of Newcastle and Children's Medical Research Institute today announced that they have entered into an exclusive licence, supply and distribution agreement for the clathrin inhibitors Pitstop 1TM and Pitstop 2TM for research. These novel compounds are the first rationally designed inhibitors of clathrin, and represent important tools for investigating essential cellular processes such as endocytosis. The agreement...


Latest Peripheral membrane proteins Reference Libraries

Paneth Cells
2012-07-01 19:03:07

Paneth Cells are one of four principal cell types found in the epithelium of the small intestine; the other three are the goblet cell, enterocyte, and enteroendocrine cell. Paneth cells may also be found in the cecum and appendix, although sporadically. These cells are identifiable microscopically by their location just below the intestinal stem cells in the intestinal glands. and the large eosinophilic refractile granules that occupy most of their cytoplasm. These granules consist of...

More Articles (1 articles) »